bioAffinity Technologies, Inc.(BIAF),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BIAF bioAffinity Technologies, Inc.

Market Closed 08-28 16:00:00 EDT

4.87

-0.19

-3.75%

盘后4.90

+0.03+0.62%

19:41 EDT

High5.17	Low4.87	Vol30.38K
Open4.95	D1 Closing5.06	Amplitude5.93%
Mkt Cap2.88M	Tradable Cap2.59M	Total Shares592.37K
T/O150.94K	T/O Rate5.71%	Tradable Shares532.20K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BIAF","market":"US","secType":"STK","nameCN":"bioAffinity Technologies, Inc.","latestPrice":4.87,"timestamp":1787947200000,"preClose":5.06,"halted":0,"volume":30375,"hourTrading":{"tag":"盘后","latestPrice":4.9,"preClose":4.87,"latestTime":"19:41 EDT","volume":1580,"amount":7696.19,"timestamp":1787960465728,"change":0.03,"changeRate":0.00616,"amplitude":0.008214},"delay":0,"changeRate":-0.03754940711462441,"floatShares":532200,"shares":592373,"eps":-59.69511,"marketStatus":"Market Closed","change":-0.19,"latestTime":"08-28 16:00:00 EDT","open":4.95,"high":5.17,"low":4.87,"amount":150937.41487500002,"amplitude":0.059289,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-59.69511,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788163200000},"marketStatusCode":7,"adr":0,"listingDate":1662004800000,"exchange":"NASDAQ","adjPreClose":5.06,"preHourTrading":{"tag":"盘前","latestPrice":4.94,"preClose":5.06,"latestTime":"09:29 EDT","volume":960,"amount":4739.82336,"timestamp":1787923770031,"change":-0.12,"changeRate":-0.023715,"amplitude":0.01002},"postHourTrading":{"tag":"盘后","latestPrice":4.9,"preClose":4.87,"latestTime":"19:41 EDT","volume":1580,"amount":7696.19,"timestamp":1787960465728,"change":0.03,"changeRate":0.00616,"amplitude":0.008214},"volumeRatio":0.33922967872410653},"requestUrl":"/m/hq/s/BIAF/wiki","defaultTab":"wiki","newsList":[{"id":"2661229198","title":"NASDAQ Trade Halt Continues Reason not Available at 03:58 Am","url":"https://stock-news.laohu8.com/highlight/detail?id=2661229198","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661229198?lang=en_us&edition=fundamental","pubTime":"2026-08-24 15:58","pubTimestamp":1787558282,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT CONTINUESREASON NOT AVAILABLE AT 03:58 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nAQN2MG7VP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BIAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661218071","title":"bioAffinity Technologies Inc trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2661218071","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661218071?lang=en_us&edition=fundamental","pubTime":"2026-08-22 07:55","pubTimestamp":1787356508,"startTime":"0","endTime":"0","summary":"19:50 EDT bioAffinity Technologies (BIAF) Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-mo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioaffinity-technologies-inc-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioaffinity-technologies-inc-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIAF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660819092","title":"bioAffinity Technologies Effects 1-for-15 Reverse Stock Split Effective Aug. 24, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2660819092","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660819092?lang=en_us&edition=fundamental","pubTime":"2026-08-20 20:00","pubTimestamp":1787227258,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies effects 1-for-15 reverse stock split effective Aug. 24, 2026bioAffinity Technologies to execute a 1-for-15 reverse stock split, effective at the open on Aug. 24, 2026.Shares t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDLBx0Zb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BIAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660281985","title":"bioAffinity Technologies Announces 1-for-15 Reverse Stock Split Effective at the Open of Trading on August 24, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2660281985","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660281985?lang=en_us&edition=fundamental","pubTime":"2026-08-20 20:00","pubTimestamp":1787227201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nTUA9QTKZV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIAFW","BK4139","BIAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660628344","title":"bioAffinity Signs AvMEDICAL Distribution Deal for CyPath Lung in Federal Healthcare Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2660628344","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660628344?lang=en_us&edition=fundamental","pubTime":"2026-08-18 20:00","pubTimestamp":1787054459,"startTime":"0","endTime":"0","summary":"bioAffinity signs AvMEDICAL distribution deal for CyPath Lung in federal healthcare marketbioAffinity Technologies entered a distribution agreement with AvMEDICAL to sell CyPath Lung across the US fed","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL1m0p8f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660464035","title":"bioAffinity Technologies and Avmedical Announce Nationwide Federal Healthcare Distribution Agreement for Cypath® Lung","url":"https://stock-news.laohu8.com/highlight/detail?id=2660464035","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660464035?lang=en_us&edition=fundamental","pubTime":"2026-08-18 20:00","pubTimestamp":1787054402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nTUA3QG35R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIAFW","BIAF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659172760","title":"BioAffinity Technologies announces closing of $4M private placement offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2659172760","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659172760?lang=en_us&edition=fundamental","pubTime":"2026-08-16 21:00","pubTimestamp":1786885219,"startTime":"0","endTime":"0","summary":"BioAffinity Technologies (BIAF) announced that it has closed its previously announced private placement priced at-the-market under Nasdaq rules for...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioaffinity-technologies-announces-closing-of-4m-private-placement-offering-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioaffinity-technologies-announces-closing-of-4m-private-placement-offering-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIAF","BK4139","NQmain","LCLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659404081","title":"bioAffinity Technologies Closes $4 Million Private Placement of Pre-Funded Warrants Priced at $0.47","url":"https://stock-news.laohu8.com/highlight/detail?id=2659404081","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659404081?lang=en_us&edition=fundamental","pubTime":"2026-08-14 23:07","pubTimestamp":1786720034,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies closes $4 million private placement of pre-funded warrants priced at $0.47bioAffinity Technologies closed a private placement of pre-funded warrants covering 8,462,027 common ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDLtnXhL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BIAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659404731","title":"bioAffinity Technologies Announces Closing of $4M Private Placement Offering Priced At-the-Market Under NASDAQ Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2659404731","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659404731?lang=en_us&edition=fundamental","pubTime":"2026-08-14 23:07","pubTimestamp":1786720020,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nTUABQDPDB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BIAF","BIAFW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659157608","title":"bioAffinity Technologies Prices USD 4 Million Private Placement at USD 0.47 Per Share Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2659157608","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659157608?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:07","pubTimestamp":1786626440,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies prices USD 4 million private placement at USD 0.47 per share unitbioAffinity Technologies priced a USD 4 million private placement, selling 8,462,027 common shares or pre-fund","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL22l9SC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659215762","title":"bioAffinity Technologies Announces Pricing of $4M Private Placement Offering Priced At-the-Market Under NASDAQ Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2659215762","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659215762?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:07","pubTimestamp":1786626420,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUABGNCJX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BIAFW","BIAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658593507","title":"Heron Therapeutics Q2 Revenue Rises on Acute Care Growth, Withdraws 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2658593507","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658593507?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:08","pubTimestamp":1786363720,"startTime":"0","endTime":"0","summary":"Heron Therapeutics Q2 revenue rises on acute care growth, withdraws 2026 outlookOverviewUS biotechnology firm's Q2 net revenue rose 1.3% yr/yr to $37.7 mlnCompany withdrew full-year 2026 guidance citi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL1N4470CA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAF","HRTX","BK4505","BK4139","LU2324357040.USD","BK4585","BK4007","PTH","AXSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657645690","title":"bioAffinity Technologies Q2 Net Income USD -3.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657645690","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657645690?lang=en_us&edition=fundamental","pubTime":"2026-08-07 20:30","pubTimestamp":1786105848,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nPLX0BPSG7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIAF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657643239","title":"bioAffinity Technologies Q2 EPS $(0.64) Beats $(2.40) Estimate, Sales $1.511M Beat $1.483M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657643239","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657643239?lang=en_us&edition=fundamental","pubTime":"2026-08-07 20:11","pubTimestamp":1786104668,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies (NASDAQ:BIAF) reported quarterly losses of $(0.64) per share which beat the analyst consensus estimate of $(2.40) by 73.33 percent. This is a 87.45 percent increase over losses of $(5.10) per","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61035878/bioaffinity-technologies-q2-eps-0-64-beats-2-40-estimate-sales-1-511m-beat-1-483m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BIAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657439356","title":"bioAffinity Q2 FY26 Net Loss Narrows to $3.4 Million; Revenue Rises 19% to $1.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657439356","media":"Reuters","labels":["shareholding","corporation","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657439356?lang=en_us&edition=fundamental","pubTime":"2026-08-07 20:02","pubTimestamp":1786104146,"startTime":"0","endTime":"0","summary":"bioAffinity Q2 FY26 net loss narrows to $3.4 million; revenue rises 19% to $1.5 millionbioAffinity Technologies posted Q2 revenue of USD 1.5 million, up 19% year over year; net loss narrowed to USD 3.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDLbFjsR3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657435706","title":"Press Release: bioAffinity Technologies Reports Second Quarter 2026 Results and Continued Strong Commercial Momentum for CyPath(R) Lung","url":"https://stock-news.laohu8.com/highlight/detail?id=2657435706","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657435706?lang=en_us&edition=fundamental","pubTime":"2026-08-07 20:00","pubTimestamp":1786104000,"startTime":"0","endTime":"0","summary":"CyPath Lung test volume increased 216% year over year in Q2 2026Company drives physician adoption of CyPath Lung and advances longitudinal clinical trialPipeline expands to include development of precision diagnostics for asthma and COPD and dermally delivered skin cancer therapeuticsSAN ANTONIO, Texas----August 07, 2026--bioAffinity Technologies, Inc. , a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases and topically delivered therapeutics for squamous and basal cell skin cancers, today reported financial results and business highlights for the quarter ended June 30, 2026.Q2 2026 Highlights and Recent Events--  CyPath Lung diagnostic test volume increased 216% during the second. quarter of 2026 compared to the second quarter of 2025.--  CyPath Lung testing revenue for the first six months of 2026 increased. 159% to approximately $835,000, compared with approximately $323,000 for. --  The Comp","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","R","BIAF","CLIA","BK4139","NPV","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656391721","title":"bioAffinity Technologies Faces NASDAQ Delisting Risk After Shares Trade Below $1 Bid-price Minimum","url":"https://stock-news.laohu8.com/highlight/detail?id=2656391721","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656391721?lang=en_us&edition=fundamental","pubTime":"2026-08-01 05:15","pubTimestamp":1785532544,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies faces Nasdaq delisting risk after shares trade below $1 bid-price minimumbioAffinity Technologies received a Nasdaq staff determination for failing the $1 minimum bid price ru","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nNDL5qHKsg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654101030","title":"BioAffinity announces publication of clinical review on CyPath Lung","url":"https://stock-news.laohu8.com/highlight/detail?id=2654101030","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654101030?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:15","pubTimestamp":1785154508,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies (BIAF) announced the publication of a comprehensive clinical review and white paper authored by Chief Medical Officer Gord...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioaffinity-announces-publication-of-clinical-review-on-cypath-lung-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioaffinity-announces-publication-of-clinical-review-on-cypath-lung-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BIAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654299017","title":"bioAffinity Publishes Clinical Framework Targeting Pulmonary Nodule Risk Stratification Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2654299017","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654299017?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:09","pubTimestamp":1785154144,"startTime":"0","endTime":"0","summary":"bioAffinity publishes clinical framework targeting pulmonary nodule risk stratification marketbioAffinity Technologies published a clinical review outlining a framework for pulmonary nodule risk strat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nNDL6YZpx8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BIAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653757052","title":"Bioaffinity Technologies - Tests Expected to be Offered as Laboratory Developed Tests Under Clia","url":"https://stock-news.laohu8.com/highlight/detail?id=2653757052","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653757052?lang=en_us&edition=fundamental","pubTime":"2026-07-22 20:08","pubTimestamp":1784722101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nFWN43O0IE:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIAFW","BK4139","BIAF"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bioaffinitytech.com;ir.bioaffinitytech.com","stockEarnings":[{"period":"1week","weight":-0.1883},{"period":"1month","weight":-0.445},{"period":"3month","weight":-0.8056},{"period":"6month","weight":-0.6937},{"period":"1year","weight":-0.9557},{"period":"ytd","weight":-0.7249}],"compareEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":0.0547},{"period":"3month","weight":0.017},{"period":"6month","weight":0.1215},{"period":"1year","weight":0.1856},{"period":"ytd","weight":0.1282}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated in 2014 and is based in San Antonio, Texas.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.125018},{"month":2,"riseRate":0.25,"avgChangeRate":-0.070787},{"month":3,"riseRate":0.5,"avgChangeRate":0.528916},{"month":4,"riseRate":0.75,"avgChangeRate":0.175283},{"month":5,"riseRate":0,"avgChangeRate":-0.203542},{"month":6,"riseRate":0.25,"avgChangeRate":-0.147014},{"month":7,"riseRate":0.5,"avgChangeRate":-0.002263},{"month":8,"riseRate":0,"avgChangeRate":-0.283358},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.17769},{"month":10,"riseRate":0.25,"avgChangeRate":-0.105345},{"month":11,"riseRate":0.25,"avgChangeRate":-0.068737},{"month":12,"riseRate":0,"avgChangeRate":-0.246482}],"exchange":"NASDAQ","name":"bioAffinity Technologies, Inc.","nameEN":"bioAffinity Technologies, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.48.0","shortVersion":"4.48.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"bioAffinity Technologies, Inc.(BIAF),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest bioAffinity Technologies, Inc.(BIAF) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"bioAffinity Technologies, Inc.,BIAF,bioAffinity Technologies, Inc.股票,bioAffinity Technologies, Inc.股票老虎,bioAffinity Technologies, Inc.股票老虎国际,bioAffinity Technologies, Inc.行情,bioAffinity Technologies, Inc.股票行情,bioAffinity Technologies, Inc.股价,bioAffinity Technologies, Inc.股市,bioAffinity Technologies, Inc.股票价格,bioAffinity Technologies, Inc.股票交易,bioAffinity Technologies, Inc.股票购买,bioAffinity Technologies, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"bioAffinity Technologies, Inc.(BIAF),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest bioAffinity Technologies, Inc.(BIAF) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}